The Journal of Organic Chemistry
Article
1
ratio of approximately 1:0.6 (isomer A = E, isomer B = Z): H NMR
(500 MHz, C6D6) δ 7.35−7.07 (isomer A + B, m, 8H), 5.66 (isomer A,
ddd, J = 6.7, 5.7, 0.9 Hz, 1H), 5.39 (isomer B, ddd, J = 8.2, 6.6,
0.5 Hz, 0.6H), 4.72 (isomer B, dd, J = 11.7, 7.9 Hz, 0.6H), 4.51
(isomer B, dd, J = 12.0, 6.1 Hz, 0.6H), 4.45 (isomer B, AB quartet, J =
11.8 Hz, 1.2H), 4.21 (isomer A, AB quartet, J = 11.8 Hz, 2H), 3.73
(isomer A, d, J = 5.5 Hz, 2H), 3.54 (isomer A, d, J = 10.7 Hz, 1H),
3.47 (isomer B, d, J = 10.5 Hz, 0.6 H), 3.16 (isomer A, d, J = 10.7 Hz,
1H), 3.13 (isomer B, J = 10.7 Hz, 0.6H), 2.59 (isomer A, 1H), 2.50
(isomer B, 0.6H), 0.53 (isomer A, 3H), 0.44−0.39 (isomer A + B, m,
6.6H); 13C NMR (125 MHz, C6D6) δ 154.3, 154.0, 138.9, 138.3,
128.3, 128.2, 128.2, 128.0, 127.6, 127.3, 126.6, 126.1, 101.3, 99.8, 77.2,
76.7, 72.2, 72.1, 66.8, 66.3, 47.9, 47.7, 28.6, 28.2, 22.8, 22.8, 19.8, 19.7;
HRMS (ESI) m/z calcd for C16H20NO3 [M + H+] 274.1438, found
274.1426.
50% EtOAc in hexanes to give 12 in 86% yield (0.39 g) as a 36% yield
of a mixture of E:Z and 50% isolated as the pure Z isomer as a thick
oil: IR 2981, 1726, 1376, 1336, 1296, 1209, 1184, 1128, 1108 cm−1.
Z isomer: 1H NMR (300 MHz, C6D6) δ 5.40 (t, J = 7.4 Hz, 1H), 3.91
(q, J = 7.2 Hz, 2H), 3.65 (dd, J = 18.1, 7.2 Hz, 1H), 3.55 (dd J =
18.1 Hz, 1H), 3.42 (d, J = 10.6 Hz, 1H), 3.13 (d, J = 10.6 Hz, 1H),
2.47 (s, 1H), 0.91 (t, J = 7.2 Hz, 3H), 0.49 (s, 3H), 0.37 (s, 3H); 13C
NMR (125 MHz, C6D6) δ 171.3, 154.8, 126.9, 97.3, 60.9, 49.0, 33.1,
28.9, 23.5, 20.6, 14.5; HRMS (ESI) m/z calcd for C12H17NO4Na
[M + Na]+ 262.1050, found 262.1050.
(Z)-Ethyl-[1-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5′,5′-di-
methyl-2′-oxospiro[aziridine-2,7′ [3]oxa[1]azabicyclo[4.1.0]-
heptan]-3-yl]acetate (12a). The compound was obtained in 42%
yield (70.1 mg) as a single diastereomer using PhIO as the oxidant and
the Z-methyleneaziridine 12 as the substrate (there was a small amount of
contamination from remaining PhtNNH2). The remainder of the
mass balance was unreacted starting material, and the yield based on
recovered starting material was 58%. The material was an off-white
solid: mp 51−52 °C; 1H NMR (300 MHz, CDCl3) δ 7.82, 7.81
(Ar, AA′BB′ pattern, 2H), 7.75, 7.74 (Ar, AA′BB′ pattern, 2H), 4.33
(d, J = 10.5 Hz, 1H), 4.26 (t, J = 6.6 Hz, 1H), 4.19 (q, J = 7.0 Hz, 2H),
3.88 (d, J = 10.5 Hz, 1H), 3.38 (s, 1H), 3.35 (dd, J = 18.0, 6.6 Hz, 1H),
3.12 (dd, J = 18.0, 6.6 Hz, 1H), 1.27 (s, 3H), 1.27 (t, J = 7.0 Hz, 3H),
1.16 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 170.8, 165.7, 156.3,
134.7, 130.3, 123.7, 78.1, 62.2, 61.3, 49.5, 43.4, 34.8, 29.8, 24.4, 20.1,
14.3; HRMS (ESI) m/z calcd for C20H21O6N3Na [M + Na]+
422.1323, found 422.1323.
(E)-2-{3-[(Benzyloxy)methyl]-5′,5′-dimethyl-2′-oxo-1H-spiro-
[aziridine-2,7′-[3]oxa[1]azabicyclo[4.1.0]heptan]-1-yl}-1H-isoin-
dole-1,3(2H)-dione (11a). A 3.5:1 E:Z ratio of the methyleneaziridine
11 was utilized as the starting material. The product (36.2 mg) was
obtained in 62% isolated yield (based on the amount of 11 present in
1
the starting material) as a white solid: mp 105−107 °C; H NMR
(500 MHz, CDCl3) δ 7.74, 7.73 (Ar, AA′BB′ pattern, 2H), 7.69, 7.68
(Ar, AA′BB′ pattern, 2H), 7.36−7.29 (m, 5H), 4.72 (d, J = 11.8 Hz,
1H), 4.61 (d, J = 11.6 Hz, 1H), 4.36 (d, J = 10.4 Hz, 1H), 4.25 (dd, J =
3.8, 3.6 Hz, 1H), 4.16 (dd, J = 11.5, 3.1 Hz, 1H), 3.93 (dd, J = 11.7,
3.7 Hz, 1H), 3.82 (d, J = 10.5 Hz, 1H), 3.70 (s, 1H), 1.23 (s, 3H), 0.93
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 165.1, 157.5, 137.4, 134.1,
130.6, 128.4, 127.9, 127.9, 123.3, 78.2, 73.6, 66.5, 63.0, 50.9, 44.9, 29.7,
23.7, 19.7; HRMS (ESI) m/z calcd for C24H24N3O5 [M + H+]
434.1711, found 434.1703.
(E)-2-(4′-Methyl-2′-oxo-3-pentyl-1H-spiro[aziridine-2,7′-[3]oxa-
[1]azabicyclo[4.1.0]heptan]-1-yl)-1H-isoindole-1,3(2H)-dione (13a).
The product was obtained in 79% yield (120.5 mg) based on the amount
of 13 present in the starting material as a white solid: mp 143−144 °C;
Ethyl 7-(carbamoyloxy)-6,6-dimethylhepta-3,4-dienoate. The
precursor for 12 was prepared in the following manner. Chlorosulfonyl
isocyanate (10.8 mmol, 1.5 equiv) was dissolved in dry CH2Cl2 (25 mL)
and placed in an ice bath. The homoallenic alcohol (1.43 g, 7.2 mmol,
1.0 equiv) was then added slowly over 20 min. Once the addition was
complete, the ice bath was removed and the reaction mixture was
stirred at rt until the starting material was consumed by TLC. The
reaction was then placed in an ice bath, and THF (6 mL) and water
(3 mL) were added to the reaction. The vessel was fitted with a reflux
condenser and refluxed until TLC indicated the reaction was com-
plete. Brine (50 mL) was added to the reaction mixture, and the
solution was extracted with CH2Cl2 (2 × 50 mL) and dried with
Mg2SO4, and the solvents were removed under reduced pressure. The
residue was subjected to silica gel chromatography (100 mL portions
of 0−50% EtOAc in hexanes gradient increased in increments of 10%)
to give the product in 87% yield (1.38 g) as a clear oil: IR 2978, 1723,
1604, 1404, 1379, 1330, 1259, 1161 cm−1; 1H NMR (300 MHz,
CDCl3) δ 5.34 (m, 1H), 5.17 (m, 1H), 4.83 (br, 2H), 4.16 (q, J =
7.3 Hz, 2H), 3.86 (s, 2H), 3.02 (dd, J = 7.0, 2.8 Hz, 2H), 1.27 (t, J =
7.3 Hz, 3H), 1.05 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 203.8,
171.73, 157.3, 99.7, 86.5, 72.8, 61.0, 35.8, 35.4, 25.0, 24.8, 14.4; HRMS
(ESI) m/z calcd for C12H19NO4Na [M + Na]+ 264.1207, found
264.1214.
(Z)-Ethyl 3-(5,5-dimethyl-2-oxo-3-oxa-1-azabicyclo[4.1.0]hept-7-
ylidene)propanoate (12). Dry CH2Cl2 (20 mL) was added to a flask
that containing 4 Å molecular sieves (1.5 g) and Rh2(esp)2 (0.062 mmol,
0.03 equiv). The material prepared above (0.46 g, 2.07 mmol, 1 equiv)
was added, and the reaction mixture was stirred for 10 min. PhIO
(4.14 mmol, 2 equiv) was then added in one portion, and the reaction
was stirred vigorously until the starting material was consumed by
TLC. The mixture was filtered through a silica gel pad and washed
several times with EtOAc. The filtrate was then concentrated under
reduced pressure. Crude NMR indicated a ratio of 1:2.8 of the E:Z
olefin isomers. The crude material was purified by silica gel
chromatography (the column was pretreated with 1% triethylamine
in hexanes). A gradient of 0−20% EtOAc in hexanes was used,
increasing the more polar component by increments of 10%. The
column was eluted with 80/20 hexanes/ethyl acetate until the green
band corresponding to Rh2(esp)2 was collected. The polarity of the
eluant was then increased to 20% ethyl acetate and slowly increased to
1
IR 2914, 1720, 1352, 1283, 1245, 1143 cm−1; H NMR (500 MHz,
CDCl3) δ 7.77, 7.76 (Ar, AA′BB′ pattern, 2H), 7.69, 7.68 (Ar, AA′BB′
pattern, 2H), 4.77 (m, 1H), 3.94 (dd, J = 7.0, 4.4 Hz, 1H), 3.86 (dd,
J = 9.3, 7.0 Hz, 1H), 2.45 (ddd, J = 14.4, 6.0, 2.1 Hz, 1H), 1.95−1.88
(m, 1H), 1.78−1.67 (overlapping signals, 3H total), 1.42−1.27
(m, 8H), 0.92 (t, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ
165.0, 157.9, 134.0, 130.5, 123.1, 76.7, 66.9, 45.5, 41.4, 31.5, 29.4, 29.2,
25.8, 22.4, 20.6, 13.9; HRMS (ESI) m/z calcd for C20H23N3O4Na
[M + Na+] 392.1581, found 392.1586.
(E)-2-(4′,4′-Dimethyl-2′-oxo-3-pentyl-1H-spiro[aziridine-2,7′-[3]-
oxa[1]azabicyclo[4.1.0]heptan]-1-yl)-1H-isoindole-1,3(2H)-dione
(14a). The product was obtained in 58% yield (125.3 mg) based on
the amount of 14 present in the starting material as a white solid: mp
1
125−126 °C; H NMR (500 MHz, CDCl3) δ 7.77, 7.76 (Ar, AA′BB′
pattern, 2H), 7.69, 7.68 (Ar, AA′BB′ pattern, 2H), 3.93 (dd, J = 7.8,
4.2 Hz, 1H), 3.83 (dd, J = 9.1, 6.8 Hz, 1H), 2.31 (dd, J = 14.9, 7.1 Hz,
1H), 1.94−1.89 (m, 1H), 1.73−1.67 (m, 3H), 1.64 (s, 3H), 1.58−1.20
(m, 8H), 0.92 (t, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ
167.7, 160.5, 136.7, 133.3, 125.9, 87.2, 70.8, 48.2, 42.7, 35.6, 34.3, 32.4,
32.0, 32.0, 28.6, 27.8, 25.1, 16.7; HRMS (ESI) m/z calcd for
C21H25N3O4Na [M + Na+] 406.1738, found 406.1730.
(E)-2-(6′-Methyl-2′-oxo-3-pentyl-1H-spiro[aziridine-2,7′-[3]oxa-
[1]azabicyclo[4.1.0]heptan]-1-yl)-1H-isoindole-1,3(2H)-dione (15a).
The product was obtained in 46% yield (53.5 mg) as an off-white,
mushy solid: mp 27−30 °C; IR 2955, 2930, 2859, 1719, 1467, 1374,
1
1277, 1246, 1185, 1158 cm−1; H NMR (500 MHz, CDCl3) δ 7.77,
7.76 (Ar, AA′BB′ pattern, 2H), 7.69, 7.68 (Ar, AA′BB′ pattern, 2H),
4.59 (ddd, J = 14.2, 11.4, 1.8 Hz, 1H), 4.38 (ddd, J = 11.4, 3.8, 2.6 Hz,
1H), 3.96 (dd, J = 7.0, 4.6 Hz, 1H), 2.14 (ddd, J = 15.0, 3.4, 2.0 Hz,
1H), 2.00 (s, 3H), 1.95−1.90 (m, 1H), 1.74−1.65 (m, 4H), 1.42−1.34
(m, 4H), 0.92 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ
165.3, 158.0, 134.0, 130.4, 123.1, 71.3, 67.4, 48.8, 46.1, 31.6, 29.3, 29.3,
25.7, 22.4, 18.2, 13.9; HRMS (ESI) m/z calcd for C20H23N3O4Na
[M + Na+] 392.1581, found 392.1570.
(E)-2-(3-Pentyl-5′,5′-dimethyl-2′-oxo-1H-spiro[aziridine-2,7′-[3]-
oxa[1]azabicyclo[4.1.0]heptan]-1-yl)-1H-isoindole-1,3(2H)-dione
(19). The enantioenriched propargyl alcohol 16 was prepared accord-
ing to literature procedure.9 The same procedure previously reported
for the synthesis of racemic 17 was used to prepare the enantioenriched
sample. High-pressure liquid chromatography (HPLC) analyses were
2452
dx.doi.org/10.1021/jo3000282 | J. Org. Chem. 2012, 77, 2446−2455